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IntroductionDO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? 
CONTAMINANTS  TYPES:
Triazines        
ORIGIN
Agriculture y other uses,
Organophosphorus pesticides 
Others CUPs
Different uses (domestic, 
farming,…)





Cosmetics, solar protectors, etc.
Industrial and other uses
Plastics additives and residues
Microplastics, etc
Additional information required 
(presence, distribution and effects 





IMPA TA pro ect an  prev ous 
projects)
COASTAL LAGOONS: MAR MENOR LAGOON (SE SPAIN)







Mar Menor: hypersaline (40 to 44 psu)
Mean depth: 3-4m (maximum 6m)
One of the main intensive horticulture 
Albujón watercourse: most important 
collector of the drainage basin of Cartagena 
growing areas in Europe. 
Field area+WWTP effluents 
Relevant touristic activity (seasonality)
Introduction
ENVIRONMENTAL COMPARTMENTS
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Molluscs: cockle, oyster,noble pen shell 
and sea snail.
Fish: Golden grey mullet  red mullet 
BIOTA BIOTA




oaccumu a on omagn ca on
WEEKLY INPUT TO MAR MENOR: PHARMACEUTICALS
MAIN SURFACE WATER INPUT: EL ALBUJÓN WATERCOURSE
IntroductionDO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? 
S l i ti i t d i t tibi ti i ieasona var a on npu s: pre om nan an o cs n spr ng,
psycopharmaceuticals and antihypertensives in summer, etc
TOTAL INPUT: 11.5 kg/year
(Moreno-González et al.,2014: Sci Tot Environ 490, 59-72)
PHARMACEUTICAL DISTRIBUTION IN SEAWATER
IntroductionDO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? 


















































































































































































































































































Moreno-González et al., 2015. Environmental Research, 138, 326-344.
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Location of sampling areas in the Mar Menor
lagoon for wild species (MMi) and for clam
field exposure (Si) in spring and autumn.
DO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? Material and methods










Fish Muscle and liver Whole specimens
Bl k bGolden grey mullet
Liza aurata 
ac  go y
Gobius niger
DO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? Material and methods
SAMPLING BIOMONITORING IN MAR MENOR LAGOON
Specimens obtained in spring and autumn sampling










(liver) Gobius niger 
  n= 50-150 n= 1 n= 10-15 n= 1-5 n= 1-5 n= 8-51 
  Code Spring Autumn Spring Autumn Spring Autumn Spring Autumn Spring Autumn Spring Autumn 
  MM1 X* X* X X X* X X X 
MM10 X* X X* X X X* X X* X X    
  MM11 X X X X* X* X X X X 
  MM15 X   X X* X X X X 
  MM18 X* X* X X* X* X X X   
  MM21 X   X* X*   
MM23 X* X X X X X X X X    
  MM25 X* X X X* X   
  MM31 X X X X X X X X X   
  MM REF X* X*   X X   
  Albujon Watercourse             X X X X     
  Avge. Large length (cm) 2.1 2.3 35.5 36.1 5.3 5.5 16.4 12.3 8.2 8.4     
  Avge. Small length (cm) 1.7 1.7         25.4 24.7         
  Avge. Small lipid content (d.w. 
%)                 20.1 48.5 1.6 1.8 
  Avge. Large lipid content (d.w. 
%)     8.8 9 43.4 46.1     29.9 37.8     
A ge REF Large length (cm)** 43 5 32 5  v .     . .     
  Avge. REF Small length (cm)**               19.5         
  Avge. REF Large lipid content (d.w. %)**    6.2 8.2                
  Avge. REF Small lipid content (d.w. %)**    
 
SAMPLING BIOMONITORING IN MAR MENOR LAGOON
Material and methodsDO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? 
Sampling period: spring and


























































Clams transplanted from a less
polluted area and immersed in
Location of sampling areas in the Mar Menor
lagoon for wild species (MMi) and for clam
field exposure (Si) in spring and autumn
stainless steel cages at four sites
(S1, S2, S3 and S4).
Concentrations determined at
t=0 7 and 21 days of exposure ., .
ANALYSIS OF PHARMACEUTICALS: SPE and UPLC/MS/MS
DO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? Material and methods
BIOTA EXTRACTION 
•Pressurized liquid extraction (PLE).
-1g of free-dry biota (muscle and molluscs).
-0.5g of free-dry liver.
-100% MeOH, Tª 50ºC, 4 cycles of 5min.
CLEAN-UP
Gel permeation chromatography (GPC)• .
-DCM/MeOH (90:10, v·v-1), 5 mL min-1 flow rate.
ANALYSIS
•Ultra-high-performance liquid chromatography coupled 
to tandem mass spectrometry (UHPLC–MS/MS).
-Electrospray Ionization (ESI) positive and    negative 
mode.
M th d d f 20 h ti l l i i fi he o propose or p armaceu ca s ana ys s n s
tissues (Huerta et al., 2013) was adapted for molluscs.
ANALYSIS OF PHARMACEUTICALS: SPE and UPLC/MS/MS
DO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? Material and methods
CLAM COCKLE SEA SNAIL NOBLE PEN SHELLMolluscs
 CLAM COCKLE SEA SNAIL NOBLE PEN SHELL 
  Recovery  LOQ  LOQ  Recovery  LOQ  Recovery LOQ  
  (%)  (n=3)  (ng g-1)  (ng g-1) (%)  (n=3)  (ng g-1) (%)  (n=3)  (ng g-1) 
β-blockers               
Atenolol 35.0  1 0.5 20.4 1.37 28.7  1.3 
 
Lower 
iCarazolol 77.6 0.2 0.1 <20 1.2 46.1  0.1 
Metropolol 49.6  0.1 0.1 21.5  0.9 36.8  0.02 
Nadolol 51.8 0.2 0.2 26.5 0.4 48.9  0.2 
Propanolol 74.7  0.5 0.6 35.8  4.4 66.2  0.6 
Sotalol 57.4  4.1 2.4 <20  1.4 36.4  1 





bi lsyc a r c rugsCarbamazepine 85.3 0.3 0.1 66.7  0.5 76.9  0.1 
Citalopram 34.0 0.3 0.1 <20  0.3 22.9  0.2 
Diazepam 68.9 0.1 0.6 63.0  0.7 67.9  0.1 
10,11-EpoxyCBZ 36.5 0.3 0.2 30.2  1.2 30.5  0.3 
2-HydroxyCBZ 47.9  0.2 0.1 45.9  0.6 47.3  0.2 
va ves
Lorazepam <20 4.7 3.6 20.0  0.3 35.5  3.9 
Sertraline 88.7 19.9 19.2 40.3 13.4 125.5  19.6 
Venlafaxine 66.0  0.1 0.2 40.1  0.99 50.6  0.07 
Antiplatelet agent               
Clopidrogel 57.3 0.02 0.3 39.3  0.3 151.9  0.3 
A l i / tina ges cs an -
inflammatories               
Codeine 41.9  0.04 0.4 27  0.3 28.4  0.04 
Diclofenac <20  0.1 0.2 <20  2.5 20.0  0.3 
Diuretic               
Hydrochlorothiazide 89 3 0 001 0 05 83 7 1 1 87 3 0 02
R  > 50% (  ) d >30% (l  SD l  id d)
. . . .  . .  .
Antihelmintics               
Levamisole 51.2 0.1 0.1 41.5  0.3 31.2  0.1 
To treat asthma               
Salbutamol 29.5 0.1 0.3 23.5  0.7 41.5  0.4 
 ecovery many cases an ow a so cons ere
Moreno-González et al., 2016. Env. Research 146, 282-298 
ANALYSIS OF PHARMACEUTICALS: SPE and UPLC/MS/MS
DO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? Material and methods
MUSCLE LIVER
Fi h G ld
  
Recovery 
(n=3) LOQ  
Recovery 
(n=3) LOQ  
  (%) (ng g-1) (%)  (ng g-1) 
β-blockers         
Atenolol 27.4 0.5 117.4 1




s : o en 
grey mullet
arazo o .  . .  .
Metropolol 31.4  0.6 91.0  2.0 
Nadolol 37.7  0.3 133.7  0.4 
Propanolol 53.6 0.4 44.2 0.4
Sotalol 20.3  0.6 121.3 6.2 
liver than in 
muscle  
Psychiatric drugs         
Carbamazepine 82.6  0.3 43.0  0.3 
Citalopram <20  0.6 136.4  1.7 
Diazepam 81.5  0.2 51.2  2.0 
10,11-EpoxyCBZ 32.8  0.2 47.0  0.4 
2-HydroxyCBZ 59.9  0.2 80.0  0.8 
Lorazepam 25.4  2.7 139.7  7.5 
Sertraline 103.8 2.6 97.2 22.1
Venlafaxine 22.9  0.09 101.5  0.5 
Antiplatelet agent   Recoveries 
  
Clopidrogel 72.9 0.1 95.6 0.6
Analgesics/anti-
inflammatories      
Codeine 26.3  0.3 195.8 2.9 






Diuretic         
Hydrochlorothiazide 92.1 0.05 20.0 0.2
Antihelmintics         
Levamisole <20 0.1 200.0 0.5 
To treat asthma
 
    
Salbutamol 38.3 0.3 109.8 0.6
 
Moreno-González et al., 2016. Env. Research 146, 282-298 
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18 out of the 20 pharmaceuticals were found at low ng g-1 .
Hydrochlorothiazide and carbamazepine were detected in all species
considered.
More pharmaceuticals were detected in fish (18) than in wild
molluscs (10), particularly in golden grey mullet muscle (16).
PHARMACEUTICALS IN MOLLUSCS
DO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? Results and discussion
 Compound Caged Clams Wild Bivalves Wild Gastropod 
 Clam Cockle Noble pen shell Sea snail 
  LOQ (%) Maximum LOQ (%) Maximum LOQ% Maximum LOQ (%) Maximum 
β-blockers   
Atenolol 0 n.d. 0 n.d. - - 0 n.d.
Carazolol 0 b.q.l. 0 n.d. 0 n.d. - -
Metropolol 0 n.d. 0 n.d. 0 n.d. 0 n.d.
Nadolol 0 n.d. 0 n.d. 0 n.d. 0 n.d.
Propanolol 5 0.3 (S1) 0 n.d. 0 n.d. 0 n.d.
Sotalol 0 n d 0 n d 0 n d. . . .  . . - -
Psychiatric drugs   
Carbamazepine 17 0.7 (S2) 15 1.5 10 0.2 7 2.3 (MM11)
Citalopram 17 0.5 (S3) 45 2.3 - - - -
Diazepam 0 n.d. 0 b.q.l. 0 n.d. 0 n.d.
10 11-EpoxyCBZ 0 n.d. 0 n.d. 0 n.d. 0 n.d.,   
2-HydroxyCBZ 0 n.d. 0 n.d. 0 n.d. 0 n.d.
Lorazepam - - - - 0 n.d. - -
Sertraline 0 n.d. 0 0 0 n.d. 0 n.d.
Venlafaxine 5 0.3 (S2) 22 1.1 37 2.7 (MM9) 7 0.4 (MM11)
Antiplatelet agent   
Clopidrogel 0 n.d. 0 n.d. 0 n.d. 0 n.d.
Analgesics/anti-   
Codeine 0 n.d. 0 n.d. - - - -
Diclofenac - - - - - - - -
Diuretic   
H d hl thi id 100 1 8 (S3) 87 1 6 63 3 2 36 1 8 (MM1)y roc oro az e .  .   .  .  
Antihelmintics   
Levamisole 0 n.d. 8 0.2 91 2.1 (MM9) 9 0.5 (MM9)
To treat asthma           
Salbutamol - - - - 0 n.d. 0 n.d. 
Moreno-González et al., 2016, Environ. Res. 146, 282-298. 
PHARMACEUTICALS IN MOLLUSCS
DO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? Results and discussion
Detected in all molluscs:















syc a r c rugs car amazep ne, c a opram, ven a ax ne ,













Hydrochlorothiazide in cockle and sea snail






























Citalopram (2.3 ng g-1) in cockle (Los Alcázares)
Hydrochlorotiazide (3.2 ng g-1) in noble pen shell (MM23)
Carbamazepine (2.3 ng g-1) in sea snail (MM11)
Moreno-González et al., 2016, Environ. Res. 146, 282-298. 
SPATIAL DISTRIBUTION OF PHARMACEUTICALS IN MOLLUSCS




















Moreno-González et al., 2016, Environ. Res. 146, 282-298. 
DO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? 




















Heterogeneous distribution: several sources also confirmed (more compounds
found in north area but higher concentrations in south)
LongitudeLongitude
Moreno-González et al., 2016, Environ. Res. 146, 282-298. 
PHARMACEUTICALS IN FISH
DO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? Results and discussion
Compound Wild Fish  
 
G.g. Mullet (liver) G.g. Mullet 
(muscle) Black goby 
 Compound LOQ (%) Maximum LOQ (%) Maximum LOQ (%) Maximum
β-blockers     
Atenolol 0 n.d. - - - - 
Carazolol 0 n.d. 22 1.7 0 b.q.l.
Metropolol 0 b.q.l. 5 0.7 0 n.d.
Nadolol 0 n.d. 28 0.6 0 n.d.
Propanolol 0 n.d. 11 0.5 0 n.d.
Higher number of
pharmaceuticals in golden
grey mullet than in
bivalves.
Sotalol 0 n.d. - - - - 
Psychiatric drugs      
Carbamazepine 33 2.6 83 6.3 1 0.4 
Citalopram 0 n.d. ‐ ‐ ‐ ‐ 
Diazepam 0 n.d. 15 1.8 1 3.5 
10 11 E CBZ 0 d 5 0 2 0 d
Muscle better tissue than
li (hi h i, - poxy  n. . .  n. .
2-HydroxyCBZ 0 n.d. 4 0.3 0 n.d.
Lorazepam 0 n.d. - - - - 
Sertraline 0 n.d. 0 n.d. 0 n.d.
Venlafaxine 22 3.1 - - - - 
Antiplatelet agent
ver g er concentrat on
but low number of
detections)
       
Clopidrogel 0 b.q.l. 5 0.2 0 n.d.
Analgesics/anti-      
Codeine 0 n.d. - - - - 




h ti lHydrochlorothiazide - - 19 10.5 25 3.9 
Antihelmintics      
Levamisole 9 0.5 - - - - 
To treat asthma      
Salbutamol 0 n.d. 5 0.6 0 n.d.
p armaceu ca s.
Moreno-González et al., 2016, Environ. Res. 146, 282-298. 
DO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? Results and discussion
PHARMACEUTICALS IN FISH
Detected in both fish species:
P hi t i d ( b i it l di )syc a r c rugs car amazep ne, c a opram, azepam ,
codeine (analgesic), carazolol (-blockers), hydrochlorotiazide
(diuretic) and levamisole (antihelmintic).
Lorazepam was only found in black goby
Atenolol was only found in golden grey mullet
Most ubiquitous compounds:
Carbamazepine and venlafaxine in mugilid muscle
Highest concentrations:
Carbamazepine(6.3 ng g-1) in G.g. mullet muscle (MM21)
Hydrochlorotiazide (3.9 ng g-1) in black goby (MM23)
Moreno-González et al., 2016, Environ. Res. 146, 282-298. 
SPATIAL DISTRIBUTION OF PHARMACEUTICALS IN FISH
DO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? Results and discussion
Psychiatric drugs in golden grey






















Concentrations of propanolol and





















S Only two pharmaceuticals were
found in g.g. mullets from
Mediterranean area (lower
Concentration of carbamazepine in 
golden grey mullet ( g kg-1 d w ) in 
Longitude
exposition).
 · . .
spring and autumn 2010 for small (S) 
and large specimens (L). 
ACTIVE BIOMONITORING: CAGED CLAMS
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CONCLUSIONS
DO PHARMACEUTICALS BIOACCUMULATE IN MARINE SPECIES? Conclusions
-The distribution of pharmaceuticals in wild organisms was
heterogeneous in the lagoon, higher concentrations close to
wastewater discharges or other pollution sources.
-Psychiatric drugs preferentially bioaccumulated in fish
muscle, while citalopram did so in molluscs. Carbamazepine
and hydrochlorothiazide were detected in all species in this
study.
-The bioaccumulation of pharmaceuticals was lower in sea
snail than in bivalves, and in black goby than in golden grey
mullet. Bioaccumulation of hydrochlorothiazide was also
confirmed in caged clams.
-The psychiatric drugs in all species were preferentially found
in spring.
- Those results suggest that mugilids could be used as an
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Thank you very much for 
your attention!
Any question?

